腎造瘻裝置市場規模、佔有率及成長分析（按產品、最終用戶及地區分類）－2026-2033年產業預測

全球腎造瘻裝置市場規模預計在 2024 年達到 14.1 億美元，從 2025 年的 15.3 億美元成長到 2033 年的 29.6 億美元，在預測期（2026-2033 年）內複合年成長率為 8.6%。

全球腎造瘻裝置市場正經歷強勁成長，這主要得益於腎臟疾病（例如尿道結石）發病率的不斷上升，這些疾病影響著相當一部分人口，以及人們對微創手術方案的認知和需求日​​益成長。腎臟疾病（包括癌症）的普遍存在使得腎造瘻裝置的使用成為必要，尤其是在尿路阻塞患者身上。此外，微創手術的優勢，例如恢復時間短、併發症少、美觀效果好，也促使人們在外科手術中越來越傾向於選擇這些裝置。然而，來自其他治療方法的競爭以及腎造瘻手術本身固有的風險等潛在挑戰可能會影響市場成長趨勢，因此需要相關人員認真考慮。

全球腎造瘻管器械市場促進因素

全球腎造瘻器械市場的主要驅動力是腎造瘻技術的顯著進步。這些進步包括：開發出更優質的導管材料、改良的影像技術以實現精準的手術引導，以及創新的引流系統，從而提升腎造瘻手術的整體有效性和安全性。隨著醫療機構不斷尋求採用尖端高效的解決方案，這些技術進步在推動市場擴張方面發揮關鍵作用。器械設計和功能的持續改進不僅改善了患者的治療效果，也鼓勵醫療專業人員在臨床實踐中採用這些先進工具，最終推動市場向前發展。

限制全球腎造瘻管器械市場的因素

腎造瘻裝置市場面臨許多限制因素，主要原因在於這些產品的高成本。這些成本不僅包括裝置本身，還包括有效使用所需的耗材和配件。這種經濟負擔會阻礙裝置的普及，尤其是在預算緊張的醫療環境中，也會對經濟困難的病人造成挑戰。因此，腎造瘻裝置的成本效益可能成為其廣泛應用的障礙，並影響某些地區和醫療機構中患者獲得這些重要醫療設備的機會。

全球腎造瘻裝置市場趨勢

由於安全性和便利性更高，全球腎造瘻裝置市場正經歷著向一次性腎造瘻裝置的顯著轉變。隨著醫療機構將病患安全放在首位，這些一次性裝置的使用率不斷提高，顯著降低了交叉感染的風險。此外，它們無需再進行處理和消毒，使其成為醫療機構更有效率的選擇。隨著對感染控制和以患者為中心的護理的日益重視，這種對一次性裝置的偏好預計將影響市場動態，並推動創新和投資，以研發符合不斷發展的醫療保健標準的先進腎造瘺解決方案。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管環境
• 案例研究
• 技術進步

全球腎造瘻裝置市場規模（依產品及複合年成長率分類）（2026-2033 年）

• 導管導引線
• 引流管
• 腎造瘻管
• 鞘套擴張器
• 其他

全球腎造瘻裝置市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 急診診所
• 門診手術中心（ASC）
• 其他

全球腎造瘻裝置市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Boston Scientific Corporation（United States）
• Teleflex Incorporated（United States）
• Becton, Dickinson and Company（United States）
• B. Braun SE（Germany）
• Cook Medical Incorporated（United States）
• Coloplast Group（Denmark）
• Olympus Corporation（Japan）
• Medtronic plc（Ireland）
• AngioDynamics Inc.（United States）
• Envaste Limited（United Kingdom）
• Medi-Globe GmbH（Germany）
• UROMED Kurt Drews KG（Germany）
• ROCAMED（France）
• Amecath（Egypt）
• SURGIMEDIK（India）
• Well Lead Medical Co., Ltd.（China）
• TROGE MEDICAL GmbH（Germany）
• Porges SA（France）
• Allium Medical Solutions Ltd.（Israel）

結論與建議

Global Nephrostomy Device Market size was valued at USD 1.41 Billion in 2024 and is poised to grow from USD 1.53 Billion in 2025 to USD 2.96 Billion by 2033, growing at a CAGR of 8.6% during the forecast period (2026-2033).

The global nephrostomy device market is experiencing robust growth, driven by increasing incidences of kidney disorders like urolithiasis, which affects a significant portion of the population, alongside rising awareness and the demand for minimally invasive surgical options. The prevalence of kidney diseases, including cancer, necessitates the use of nephrostomy devices, especially in patients facing urinary blockages. Furthermore, the advantages of minimally invasive surgery, such as shorter recovery times, reduced complications, and enhanced cosmetic results, are contributing to the rising preference for these devices in surgical procedures. However, potential challenges, including competition from alternative treatments and inherent risks associated with nephrostomy procedures, could impact growth dynamics, warranting careful consideration by stakeholders within the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nephrostomy Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nephrostomy Device Market Segments Analysis

Global Nephrostomy Device Market is segmented by Product, End User and region. Based on Product, the market is segmented into Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators and Others. Based on End User, the market is segmented into Hospital, Emergency Clinics, Ambulatory Surgical Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nephrostomy Device Market

The Global Nephrostomy Device market is primarily driven by significant advancements in nephrostomy technology, including the development of superior catheter materials, enhanced imaging methods for precise procedural guidance, and innovative drainage systems that improve the overall effectiveness and safety of nephrostomy procedures. As healthcare providers continuously strive to adopt cutting-edge and efficient solutions, these technological improvements play a crucial role in fostering market expansion. The ongoing evolution in device design and functionality not only enhances patient outcomes but also encourages medical professionals to implement these advanced tools within clinical settings, ultimately propelling the market forward.

Restraints in the Global Nephrostomy Device Market

The nephrostomy device market faces significant constraints primarily due to the elevated costs associated with these products. This expense encompasses not only the devices but also the necessary consumables and accessories needed for effective use. Such financial implications can hinder adoption in various healthcare environments, particularly those with tighter budgets, and can present challenges for patients who are experiencing financial difficulties. As a result, the affordability of nephrostomy devices poses a barrier to their widespread utilization, potentially impacting patient access to these important medical tools in certain regions and healthcare settings.

Market Trends of the Global Nephrostomy Device Market

The Global Nephrostomy Device market is witnessing a notable shift towards disposable nephrostomy devices, driven by their enhanced safety features and convenience. Healthcare providers are prioritizing patient safety, leading to increased adoption of these single-use devices that significantly reduce the risk of cross-contamination and infection. Additionally, the elimination of reprocessing and sterilization requirements makes them a more efficient option for healthcare facilities. As the emphasis on infection control and patient-centric care grows, this preference for disposable devices is anticipated to shape market dynamics, encouraging innovations and investments in advanced nephrostomy solutions tailored to meet evolving healthcare standards.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Nephrostomy Device Market Size by Product & CAGR (2026-2033)

• Market Overview
• Guidewires
• Drainage Tubes
• Nephrostomy Catheters
• Sheath Dilators
• Others

Global Nephrostomy Device Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospital
• Emergency Clinics
• Ambulatory Surgical Centers (ASCs)
• Others

Global Nephrostomy Device Market Size & CAGR (2026-2033)

• North America (Product, End User)
  • US
  • Canada
• Europe (Product, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coloplast Group (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Envaste Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medi-Globe GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UROMED Kurt Drews KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ROCAMED (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amecath (Egypt)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SURGIMEDIK (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Well Lead Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TROGE MEDICAL GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Porges SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allium Medical Solutions Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations